Hemoglobin‐based Red Blood Cell Substitutes
- 20 August 2004
- journal article
- review article
- Published by Wiley in Artificial Organs
- Vol. 28 (9) , 789-794
Abstract
Abstract: Polyhemoglobin is already well into the final stages of clinical trials in humans with one approved for routine clinical use in South Africa. Conjugated hemoglobin is also in ongoing clinical trials. Meanwhile, recombinant Hb has been modified to modulate the effects of nitric oxide. Other systems contain antioxidant enzymes for those clinical applications that may have potential problems related to ischemia‐reperfusion injuries. Other developments are based on hemoglobin‐lipid vesicles and also the use of nanotechnology and biodegradable copolymers to prepare nanodimension artificial red blood cells containing hemoglobin and complex enzyme systems.Keywords
This publication has 28 references indexed in Scilit:
- Blood product from cattle wins approval for use in humansNature, 2001
- Recent developments in hemoglobin-based oxygen carriers – an update on clinical trialsTransfusion and Apheresis Science, 2001
- Resuscitative effects of polynitroxylated αα-cross-linked hemoglobin following severe hemorrhage in the ratFree Radical Biology and Medicine, 2000
- Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndromeExpert Opinion on Pharmacotherapy, 1999
- Submicron Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: Preparation and CharacterizationArtificial Cells, Blood Substitutes, and Biotechnology, 1996
- A New Resuscitation Fluid “Stabiilized Hemoglobin” Preparation and CharacteristicsBiomaterials, Artificial Cells and Artificial Organs, 1988
- Conjugated Hemoglobin: Rightshifted Dextran-Hemoglobin as Blood SubstituteBiomaterials, Artificial Cells and Artificial Organs, 1988
- 30th Anniversary in Artificial Red Blood Cell ResearchBiomaterials, Artificial Cells and Artificial Organs, 1988
- Stablisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehydeBiochemical and Biophysical Research Communications, 1971
- BLOOD SUBSTITUTESBiological Reviews, 1937